Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. - Wikidata - awgldk - TriplyDB

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

http://www.wikidata.org/entity/Q37163466

about

HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1 Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy The balance of powers: Redox regulation of fibrogenic pathways in kidney injury Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.Pericytes, an overlooked player in vascular pathobiology Role of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An Update Store-operated calcium entry and diabetic complications Cytochrome P450 eicosanoids in hypertension and renal disease Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment 20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.RNA Viruses: ROS-Mediated Cell Death.Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes.The Role of SIRT1 in Diabetic Kidney Disease.Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway Lipid raft redox signaling: molecular mechanisms in health and disease.Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.EGF receptor deletion in podocytes attenuates diabetic nephropathy.p47(phox) contributes to albuminuria and kidney fibrosis in mice.Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes.Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress.IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents.The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury.Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells Protective effects of leukemia inhibitory factor against oxidative stress during high glucose-induced apoptosis in podocytes.Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-A(y) mice Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4.Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress

P2860

Q24600332-00F03C8F-BDA3-4A0B-BCCA-D99E9F2F31F4 Q26769787-895DE2AE-0F28-4D5A-8729-52FBD0666EF1 Q26786137-0ABD2C8A-E415-496A-8041-3DC7A2ACE577 Q27343126-EFFBB28A-0015-40A1-9E97-35FDE5E462AC Q28070053-65ACA2EE-EFBE-45C9-948B-E59C38800F76 Q28074668-CE5C409F-BFF4-4F40-AD43-504BF9180ECA Q28085037-14BAFBCD-5667-4B07-A267-77F98570CCAD Q28252210-CC3E9E8C-12C8-4520-AE06-18659B10EC3C Q33610151-A175F48D-50FE-4721-901D-CDF54E5B5AA6 Q33636288-C1F2D546-967C-42AE-94DB-01E63DE7A794 Q33668416-B38B9DEA-4F52-429D-BEDA-96A4BBD631DE Q33729668-F68CE00C-D97E-43D2-B436-B0190164E07B Q33733309-7EBECCCF-524D-44EA-A0D0-A5370AC91FE3 Q34312543-0B485230-220C-476F-A0FB-34C56B54E869 Q34321681-43625E0F-858B-41D0-95BD-8DC73011361A Q34333672-4F998877-69B2-43DA-A3F3-BE9C0C45E1EC Q34427292-0C3DFD82-7996-4B3D-87DD-7D27E1288221 Q34441033-2F251704-4FA0-4AC4-BE23-B20251155D40 Q34653233-2A63C0DE-2E34-4DCB-8C30-9CE32446DB92 Q34801482-CE77DC40-C23E-4593-A0DE-E64F65EBBCA1 Q34924935-7920C4ED-E1F7-4739-BD61-D17EDBA50721 Q35101890-D9CF2147-3B71-45A7-977B-687F2BCB9C4D Q35450699-4514AFF3-CE6D-412D-9C0E-18E677CCEB58 Q35550573-9BE657A2-ADB6-4645-88DE-9D7E27F87161 Q35587361-BBE5807C-5AC6-44EB-9551-CCA957FEE5B1 Q35664105-EE8CA729-44BC-4E7E-BDEC-3E0AA85599A6 Q35671828-88E1AAE5-2FE6-4C55-B20F-CE448E2B0E28 Q35707118-AFC38927-B0E3-4FC1-AA96-73897535F6AD Q35762675-8D8FFED2-3E3B-4426-AFCD-B9F1C7B04A0F Q35895695-A84D513A-1D21-4DC5-9777-95B6E8087231 Q35919773-E3B62D04-4DBC-437B-8B6C-DA7F9E35C8AF Q35931854-556EAD45-F6DC-400A-802D-0C97CB36790F Q35989063-99988F54-A377-45B5-B730-5AD1C0057067 Q36001842-D7C2D511-F312-4D84-AA68-B7FE067D47AF Q36010534-A141B660-4020-4181-9B69-C710851F28C3 Q36140981-70E9E296-1B74-4D3C-B5B7-B170F400DE72 Q36312399-CF27F23F-3713-4306-8ACE-072B1F55C3DA Q36314892-D6446B81-9CA4-4E51-9E0A-2DD6D66E9583 Q36345943-2BDC4D1B-1129-4CA9-A1D9-7FC867421321 Q36349962-7A5865B7-BC23-428C-9DA8-913C93853E61

P2860

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

http://www.wikidata.org/entity/Q37163466

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

@en

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

@nl

type

label

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

@en

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

@nl

prefLabel

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

@en

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

@nl

P1433

Q37163466-9EEBF600-42C8-4106-8B21-2DC2C1D43570

P1476

Q37163466-E6D3FF4E-0441-422F-91F5-7B651FA30F78

P2093

Q37163466-0A22C52A-D3A5-4FC6-8DA3-F980B30A131C

Q37163466-2340B3FC-9EDC-4DC4-80F2-8E62E1F37D1A

Q37163466-276921C1-EBE2-401B-8224-F6C47C2DDF54

Q37163466-69F3C4A2-D1F1-4094-9853-39B08CD31B5E

Q37163466-A3059930-E5E2-4A24-AACD-F4A4E3C45925

Q37163466-BA0CC57C-E5F5-4028-BC1B-C4FABB21835A

P2860

Q37163466-049FC77F-E36D-4625-B342-16F452EB320E

Q37163466-08920A35-5BEB-4A71-A179-9F56A6A9DC95

Q37163466-1189B213-DBAC-440A-BC6A-7B18176BDD3B

Q37163466-1A1BE5CA-E526-4362-BD3B-EDEFBC062F6A

Q37163466-20A03938-97AC-4562-99B8-9BB8F56104BA

Q37163466-2563683D-C820-4AB0-A528-F5A63E238889

Q37163466-331C47FB-EC2F-4DCA-B703-D16BDE86C515

Q37163466-38D4885A-1050-41D4-9179-827269DC0D63

Q37163466-4BACAB7A-E7D7-4D94-A6FB-5A513404FFFC

Q37163466-4EAC4F31-E884-4F05-B913-095FF1232282

P304

Q37163466-4E8937FA-00A6-453C-A96D-6C080E7A128E

P31

Q37163466-90E8AC49-0686-4DE5-9C11-87DBF2C301BB

P356

Q37163466-79C554F7-E92F-4642-872B-F97E227B192C

P407

Q37163466-DFEA1FCB-0AE3-468D-9D5E-F75537ED7D1C

P433

Q37163466-ED7A625D-8884-40DF-B23A-9A33899E520C

P478

Q37163466-777B99E1-6757-484D-B1DB-E972FCB2705A

P50

Q37163466-20E69CAB-CFD5-40CD-ADAF-89674AF95610

P577

Q37163466-239CB8BD-1EFF-4D0C-97B2-5412F76BD36D

P5875

Q37163466-CAD75AF8-CCCC-4504-957C-67F2BD93F3E7

P698

Q37163466-FC054CEA-784D-4160-A112-08E832F1A1C5

P932

Q37163466-C20E7526-7A2E-4EE4-A834-B70B1A344FF2

P356

P1433

P1476

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.

@en

P2093

Assaad A Eid

http://www.w3.org/2001/XMLSchema#string

Bridget M Fagg

http://www.w3.org/2001/XMLSchema#string

Hanna E Abboud

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Barnes

http://www.w3.org/2001/XMLSchema#string

Karen Block

http://www.w3.org/2001/XMLSchema#string

Rita Maalouf

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin regulates albuminuria and podocyte function in mice

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme

Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.

The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment.

Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids.

Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis.

HETEs/EETs in renal glomerular and epithelial cell functions.

P304

1201-1211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB08-1536

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23999320

http://www.w3.org/2001/XMLSchema#string

P698

19208908

http://www.w3.org/2001/XMLSchema#string

P932

2671039

http://www.w3.org/2001/XMLSchema#string